Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Baxter
Cerilliant
Cantor Fitzgerald
McKesson
Farmers Insurance
Boehringer Ingelheim
Mallinckrodt
Julphar

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050705

« Back to Dashboard

NDA 050705 describes RIFATER, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. Additional details are available on the RIFATER profile page.

The generic ingredient in RIFATER is isoniazid; pyrazinamide; rifampin. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the isoniazid; pyrazinamide; rifampin profile page.
Summary for 050705
Tradename:RIFATER
Applicant:Sanofi Aventis Us
Ingredient:isoniazid; pyrazinamide; rifampin
Patents:0
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 050705
Ingredient-typeRifamycins
Suppliers and Packaging for NDA: 050705
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIFATER isoniazid; pyrazinamide; rifampin TABLET;ORAL 050705 NDA sanofi-aventis U.S. LLC 0088-0576 N 0088-0576-41

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG;300MG;120MG
Approval Date:May 31, 1994TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Dow
UBS
Deloitte
AstraZeneca
US Department of Justice
Citi
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.